Candida albicans and Candida glabrata Clinical Isolates Exhibiting Reduced Echinocandin Susceptibility

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2006-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.00349-06PMID 16870797PMCID PMC1538661
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis.

  2006cited by this paper
• In Vitro Susceptibilities of Candida spp. to Caspofungin: Four Years of Global Surveillance

  2006cited by this paper
• Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient.

  2006cited by this paper
• Multiechinocandin- and Multiazole-Resistant Candida parapsilosis Isolates Serially Obtained during Therapy for Prosthetic Valve Endocarditis

  2005cited by this paper
• Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical Candida sp. Isolates

  2005influential reference
• Promoter-dependent disruption of genes: simple, rapid, and specific PCR-based method with application to three different yeast

  2005cited by this paper
• Emergence of disseminated candidiasis caused by Candida krusei during treatment with caspofungin: case report and review of literature.

  2005cited by this paper
• FKS1 Mutations Responsible for Selective Resistance of Saccharomyces cerevisiae to the Novel 1,3-β-Glucan Synthase Inhibitor Arborcandin C

  2004cited by this paper
• Genome evolution in yeasts

  2004cited by this paper
• Caspofungin Resistance in Candida albicans: Correlating Clinical Outcome with Laboratory Susceptibility Testing of Three Isogenic Isolates Serially Obtained from a Patient with Progressive Candida Esophagitis

  2004cited by this paper
• Echinocandin antifungal drugs.

  2003cited by this paper
• Caspofungin Activity against Clinical Isolates of Fluconazole-Resistant Candida

  2003cited by this paper
• Histone Deacetylase Inhibitors Enhance Candida albicans Sensitivity to Azoles and Related Antifungals: Correlation with Reduction in CDR and ERG Upregulation

  2002cited by this paper
• Prospective, Multicenter Surveillance Study of Candida glabrata: Fluconazole and Itraconazole Susceptibility Profiles in Bloodstream, Invasive, and Colonizing Strains and Differences between Isolates from Three Urban Teaching Hospitals in New York City (Candida Susceptibility Trends Study, 1998 to 1

  2002cited by this paper
• Glucan synthase inhibitors as antifungal agents.

  2001cited by this paper
• Fungal β(1,3)-d-glucan synthesis

  2001cited by this paper
• Fungal beta(1,3)-D-glucan synthesis.

  2001influential reference
• National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program.

  1998cited by this paper
• National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathogens of Epidemiologic.

  1998cited by this paper
• Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance

  1998cited by this paper
• In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi.

  1998cited by this paper
• Comparison of In Vitro Activities of the New Triazole SCH56592 and the Echinocandins MK-0991 (L-743,872) and LY303366 against Opportunistic Filamentous and Dimorphic Fungi and Yeasts

  1998cited by this paper
• Cloning of the Candida albicans homolog of Saccharomyces cerevisiae GSC1/FKS1 and its involvement in beta-1,3-glucan synthesis

  1997cited by this paper
• Characterization of echinocandin-resistant mutants of Candida albicans: genetic, biochemical, and virulence studies

  1996cited by this paper

• A Candidozyma (Candida) auris–Optimized Episomal Plasmid–Induced Cas9-Editing System Reveals the Direct Impact of the S639F-Encoding FKS1 Mutation

  2025cites this paper
• The yEvo Mutation Browser: Enhancing student understanding of experimental evolution and genomics through interactive data visualization

  2025cites this paper
• Beyond Conventional Antifungals: Combating Resistance Through Novel Therapeutic Pathways

  2025cites this paper
• Biofilm-Associated Candidiasis: Pathogenesis, Prevalence, Challenges and Therapeutic Options

  2025cites this paper
• Nakaseomyces glabratus (Candida glabrata) MLST Genotypes in Central Poland

  2025cites this paper
• Identification, purification and functional characterization of a thermostable marine chitinase for potential fungal control via chitin degradation mechanism.

  2025cites this paper
• Anidulafungin is a useful surrogate marker for predicting in vitro susceptibility to rezafungin among five Candida species using CLSI methods and interpretive criteria

  2025cites this paper
• Is metabolic generalism the Breakfast of Champions for pathogenic Candida species?

  2024cites this paper
• The Emerging Pathogen Candida metapsilosis: Biological Aspects, Virulence Factors, Diagnosis, and Treatment

  2024cites this paper
• Molecular Epidemiology and Antifungal Susceptibility Profile in Nakaseomyces glabrata Species Complex: A 5‐Year Countrywide Study

  2024cites this paper
• Candida parapsilosis Virulence and Antifungal Resistance Mechanisms: A Comprehensive Review of Key Determinants

  2023cites this paper
• Molecular Mechanisms Associated with Antifungal Resistance in Pathogenic Candida Species

  2023cites this paper
• Breakthrough candidemia with hematological disease: Results from a single-center retrospective study in Japan, 2009–2020

  2023cites this paper
• Candida glabrata: A powerhouse of resistance

  2023cites this paper
• Is There a Relationship Between Mating and Pathogenesis in Two Human Fungal Pathogens, Candida albicans and Candida glabrata?

  2023cites this paper
• Fluconazole and echinocandin resistance of Candida species in invasive candidiasis at a university hospital during pre-COVID-19 and the COVID-19 outbreak

  2023cites this paper
• Reshaping Echinocandin Antifungal Drugs To Circumvent Glucan Synthase Point-Mutation-Mediated Resistance.

  2023cites this paper
• Susceptibility to caspofungin is regulated by temperature and is dependent on calcineurin in Candida albicans

  2023cites this paper
• Neue Antimykotika: Hoffnungsträger in der Therapie invasiver Mykosen?

  2022cites this paper
• Machine Learning for Antimicrobial Resistance Research and Drug Development

  2022cites this paper
• Echinocandins Susceptibility Patterns of 2,787 Yeast Isolates: Importance of the Thresholds for the Detection of FKS Mutations

  2022cites this paper
• Synergistic Antifungal Activity of Synthetic Peptides and Antifungal Drugs against Candida albicans and C. parapsilosis Biofilms

  2022cites this paper
• Benzylic Dehydroxylation of Echinocandin Antifungal Drugs Restores Efficacy against Resistance Conferred by Mutated Glucan Synthase

  2022cites this paper
• Caspofungin resistance in Candidaalbicans: genetic factors and synergistic compounds for combination therapies

  2022cites this paper
• Echinocandins

  2021cites this paper
• Can We Improve Antifungal Susceptibility Testing?

  2021cites this paper
• Emergence of resistant Candida glabrata in Germany

  2021cites this paper
• Impact of FKS1 Genotype on Echinocandin In Vitro Susceptibility in Candida auris and In Vivo Response in a Murine Model of Infection

  2021cites this paper
• Emerging Echinocandin Resistance – A Review

  2021cites this paper
• Danish Whole-Genome-Sequenced Candida albicans and Candida glabrata Samples Fit into Globally Prevalent Clades

  2021cites this paper
• Caspofungin resistance in clinical Aspergillus Flavus isolates.

  2021cites this paper
• Crosstalk between the calcineurin and cell wall integrity pathways prevents chitin overexpression in Candida albicans

  2021cites this paper
• Candida auris: a bibliometric analysis of the first ten years of research (2009–2018)

  2020cites this paper
• Revisiting Old Questions and New Approaches to Investigate the Fungal Cell Wall Construction.

  2020cites this paper
• An Overview on Conventional and Non-Conventional Therapeutic Approaches for the Treatment of Candidiasis and Underlying Resistance Mechanisms in Clinical Strains

  2020cites this paper
• Caspofungin resistance in Candia auris due to mutations in Fks1 with adjunctive role of chitin and key cell wall stress response pathway genes

  2020cites this paper
• Candida albicans Antifungal Resistance and Tolerance in Bloodstream Infections: The Triad Yeast-Host-Antifungal

  2020cites this paper
• A comprehensive overview of the medicinal chemistry of antifungal drugs: perspectives and promise.

  2020cites this paper
• Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond.

  2020cites this paper
• Antifungal Susceptibility Profile of Candida Albicans Isolated from Vulvovaginal Candidiasis in Xinjiang Province of China

  2019cites this paper
• Genome-Wide Response to Drugs and Stress in the Pathogenic Yeast Candida glabrata.

  2019cites this paper
• The Fungal Histone Acetyl Transferase Gcn5 Controls Virulence of the Human Pathogen Candida albicans through Multiple Pathways

  2019cites this paper
• Antifungal Consideration for Transplant Recipients

  2019cites this paper
• Microevolution of the pathogenic yeasts Candida albicans and Candida glabrata during antifungal therapy and host infection

  2019cites this paper
• Analysis of antifungal resistance genes in Candida albicans and Candida glabrata using next generation sequencing

  2019cites this paper
• The fungal cell wall as a target for the development of new antifungal therapies.

  2019cites this paper
• Phytochemicals and Their Antifungal Potential against Pathogenic Yeasts

  2019cites this paper
• Lack of detection of Candida nivariensis and Candida bracarensis among 440 clinical Candida glabrata sensu lato isolates in Kuwait

  2019cites this paper
• The Mechanisms of Mating in Pathogenic Fungi—A Plastic Trait

  2019cites this paper
• Prevalence and Antifungal Susceptibility of the Emerging Fungal Species, Candida nivariensis, Isolated in a Teaching Hospital in Poland

  2019cites this paper
• Proteomics Analysis of Candida albicans dnm1 Haploid Mutant Unraveled the Association between Mitochondrial Fission and Antifungal Susceptibility

  2019cites this paper
• Dermaseptin‐S1 decreases Candida albicans growth, biofilm formation and the expression of hyphal wall protein 1 and aspartic protease genes

  2018influential citation
• Cooperation between ER stress and calcineurin signaling contributes to the maintenance of cell wall integrity in Candida glabrata.

  2018cites this paper
• Effets de la dermaseptine-S 1 sur la croissance, la transformation, la formation de biofilms et l'expression de certains gènes de virulence de C. albicans

  2018cites this paper
• Candida Infections and Therapeutic Strategies: Mechanisms of Action for Traditional and Alternative Agents

  2018cites this paper
• Presence of L701 M mutation in the FKS1 gene of echinocandin-susceptible Candida krusei isolates.

  2018cites this paper
• Targeting Candida spp. to develop antifungal agents.

  2018cites this paper
• Role of FKS Gene in the Susceptibility of Pathogenic Fungi to Echinocandins.

  2018cites this paper
• Activity of Combined Antifungal Agents Against Multidrug-Resistant Candida glabrata Strains

  2017cites this paper
• High-temperature ethanol production using thermotolerant yeast newly isolated from Greater Mekong Subregion

  2017cites this paper
• Antifungal Resistance, Metabolic Routes as Drug Targets, and New Antifungal Agents: An Overview about Endemic Dimorphic Fungi

  2017cites this paper
• Use of Novel Tools to Probe Drug Resistance in Fungi

  2017cites this paper
• Sequencing of FKS Hot Spot 1 from Saprochaete capitata To Search for a Relationship to Reduced Echinocandin Susceptibility

  2017cites this paper
• Chemical inhibitors of Candida albicans hyphal morphogenesis target endocytosis

  2017cites this paper
• Antifungal drug resistance in pathogenic fungi

  2016cites this paper
• The fungal resistome: a risk and an opportunity for the development of novel antifungal therapies.

  2016cites this paper
• Recurrent episodes of Candidemia due to Candida glabrata, Candida tropicalis and Candida albicans with acquired echinocandin resistance

  2016cites this paper
• Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus

  2016cites this paper
• KRE5 Suppression Induces Cell Wall Stress and Alternative ER Stress Response Required for Maintaining Cell Wall Integrity in Candida glabrata

  2016cites this paper
• The role of the FKS1 gene in nosocomial Candida albicans isolates' virulence and antifungal resistance

  2015influential citation
• Mechanisms of Antifungal Drug Resistance.

  2015cites this paper
• Mechanisms of Resistance to Antifungal Agents

  2015cites this paper
• Effect of fetal bovine serum on Candida glabrata cultures

  2015cites this paper
• Quick Detection of FKS1 Mutations Responsible for Clinical Echinocandin Resistance in Candida albicans

  2015cites this paper
• Candida parapsilosis, C. orthopsilosis y C. metapsilosis: epidemiología de las candidemias, patrones de sensibilidad y mecanismos de resistencia a las equinocandinas

  2015cites this paper
• Genomic analysis of a Candida glabrata clinical isolate resistant to antifungals unveils novel features of drug resistance in this pathogenic yeast

  2015cites this paper
• Mechanisms of echinocandin antifungal drug resistance

  2015cites this paper
• Old and new pathogenic Nakaseomyces species: epidemiology, biology, identification, pathogenicity and antifungal resistance.

  2015cites this paper
• Mechanisms of Action of Antifungal Agents

  2015cites this paper
• Antifungal resistance does not necessarily affect Candida glabrata fitness

  2014cites this paper
• Target Enzyme Mutations Confer Differential Echinocandin Susceptibilities in Candida kefyr

  2014cites this paper
• Identification and strain typing of Candida albicans isolates from clinical samples

  2014cites this paper
• Phenotypic Analysis of a Family of Transcriptional Regulators, the Zinc Cluster Proteins, in the Human Fungal Pathogen Candida glabrata

  2014cites this paper
• Post-mortem analysis of Candida albicans breakthrough infection during echinocandin treatment in haematopoietic stem cell transplant recipient.

  2014cites this paper
• In Vitro Antifungal Susceptibility of Candida glabrata to Caspofungin and the Presence of FKS Mutations Correlate with Treatment Response in an Immunocompromised Murine Model of Invasive Infection

  2014cites this paper
• Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy?

  2014cites this paper
• Paradoxical antifungal activity and structural observations in biofilms formed by echinocandin-resistant Candida albicans clinical isolates.

  2014cites this paper
• Set of Classical PCRs for Detection of Mutations in Candida glabrata FKS Genes Linked with Echinocandin Resistance

  2014cites this paper
• Phenotypic and molecular antifungal susceptibility testing of yeast isolates from Pretoria

  2014cites this paper
• Acquired echinocandin resistance in a Candida krusei blood isolate confirmed by mutations in the fks1 gene.

  2014cites this paper
• Breakthrough Invasive Candida glabrata in Patients on Micafungin: a Novel FKS Gene Conversion Correlated with Sequential Elevation of MIC

  2014cites this paper
• Interplay between Candida albicans and the Antimicrobial Peptide Armory

  2014cites this paper
• Echinocandin Resistance, Susceptibility Testing and Prophylaxis: Implications for Patient Management

  2014influential citation
• In vitro Inhibition of Growth and Virulence Factors Production in Azole-Resistant Strains of Non-albicans Candida by Cinnamomum verum, Cymbopogon citratus, Cymbopogon martini and Syzygium aromaticum Essential Oils

  2013cites this paper
• Résistance des Candida aux antifongiques : détection et mécanismes

  2013cites this paper
• Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations.

  2013cites this paper
• Novel Antifungal Drug Discovery Based on Targeting Pathways Regulating the Fungus-Conserved Upc2 Transcription Factor

  2013cites this paper
• Undressing the fungal cell wall/cell membrane--the antifungal drug targets.

  2013cites this paper
• Assessment of antifungal effect of omeprazole on CANDIDA ALBICANS

  2013cites this paper
• Echinocandins: production and applications

  2013influential citation